---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-23-000067"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T03:35:11.432202+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Elevance Health annual meeting: directors elected, say-on-pay approved, two shareholder proposals defeated

## Summary
- All four director nominees elected with >96% of votes cast; terms expire 2026.
- Advisory vote on executive compensation approved with 187.5M for (93.6% of votes cast).
- Shareholder proposal for special meeting rights (10% threshold) not approved: 91.7M for vs 107.7M against.
- Shareholder proposal on third-party reporting rejected: 16.1M for vs 181.8M against.
- Ratification of Ernst & Young as auditor for 2023 passed with 197.1M for (92.3% of votes cast).

## SEC filing metadata
- accession: 0001156039-23-000067
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603923000067/0001156039-23-000067-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603923000067/elv-20230510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-23-000067
- JSON: https://secwatch.observer/filing/0001156039-23-000067.json
- Plain text: https://secwatch.observer/filing/0001156039-23-000067.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.